Effects of WR-2721 and cyclophosphamide on the cell cycle phase specificity of apoptosis in mouse bone marrow

Anti-Cancer Drugs

Volumn 13, Issue 7, 2002, Pages 751-758

  Mazur, L ^a   Augustynek, A ^a   Deptala A ^a   Halicka, H D ^a   Bedner, E ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Apoptosis; Bone marrow cells; Cell cycle; Cyclophosphamide; Laser scanning cytometry; WR 2721

Indexed keywords

AMIFOSTINE; CYCLOPHOSPHAMIDE; ALKYLATING AGENT; ANTIMETABOLITE; BROXURIDINE; DIAGNOSTIC AGENT; DNA; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL CYCLE; CELL DEATH; CELL LABELING; CONTROLLED STUDY; CYTOMETRY; DNA STRAND BREAKAGE; DRUG ACTIVITY; DRUG EFFECT; LASER MICROSCOPY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DNA DAMAGE; IMAGE CYTOMETRY; PHYSIOLOGY; TISSUE FIXATION;

AMIFOSTINE; ANIMAL; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BONE MARROW CELLS; BROMODEOXYURIDINE; CELL COUNT; CELL CYCLE; CYCLOPHOSPHAMIDE; DNA DAMAGE; DNA, NEOPLASM; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; G0 PHASE; G1 PHASE; IMAGE CYTOMETRY; MALE; MICE; S PHASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE FIXATION; ANIMALS;

EID: 0036667946     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200208000-00010     Document Type: Article

References (27)

1. Apoptosis
2. Molecular mechanisms of apoptosis
3. Apoptosis in the hemopoietic system
4. Apoptosis and the cell cycle
5. Cell cycle and apoptosis: Common pathways to life and death
6. Apoptosis in the immune system
7. Apoptosis in the white blood cell system
8. Apoptosis and cancer chemotherapy
9. Chemotherapy-induced apoptosis
10. Chemoprotection in anticancer therapy: The emerging role of Amifostine (WR-2721)
11. Protection of normal tissues from radiation and cytotoxic therapy: The development of Amifostine
12. Effects of GSH and WR-2721 on induction of micronuclei by cyclophosphamide
13. Immunocytochemical analysis of apoptotic bone marrow cells after treatment of mice with WR-2721 and chemotherapeutic drugs
14. Analysis of apoptosis by flow and laser scanning cytometry
15. Measurement of apoptosis
16. DNases and apoptosis
17. Apoptotic DNA fragmentation
18. Review: Nuclear events in apoptosis
19. Analysis of apoptosis by laser scanning cytometry
20. Laser-scanning cytometry: A new instrumentation with many application
21. Use of flow and laser-scanning cytometry in analysis of cell death
22. Clinical pharmacokinetics of cyclophosphamide
23. Pharmacokinetic profile of Amifostine
24. Reducing the toxicity of anticancer therapy: New strategies
25. The potential of Amifostine: From cytoprotectant to therapeutic agent
26. The molecular effect of acrolein
27. Hematopoietic recovery in mice treated with WR-2721 and cyclophosphamide